biologia - Studia

M. C. ALUPEI, R. M. MAXIM, M. BANCIU
Lopez-Lazaro, M. (2010). A New View of Carcinogenesis and an Alternative Approach to
Cancer Therapy. Mol. Med., 16, 144-153.
Miller, T.W., Isenberg, J.S., Roberts, D.D. (2009). Molecular Regulation of Tumor
Angiogenesis and Perfusion via Redox Signaling. Chem. Rev., 109 (7), 3099-3124.
Nakayama, T., Yao, L., Tosato, G. (2004). Mast cell-derived angiopoietin-1 plays a critical
role in the growth of plasma cell tumors. J. Clin. Invest. 114, 1317–1325.
Naldini, A., Carraro, F. (2005). Role of inflammatory mediators in angiogenesis. Curr. Drug
Targets Inflamm. Allergy, 4, 3-8.
Qutub A.A, Popel A.S., (2008) Reactive Oxygen Species Regulate Hypoxia-Inducible Factor
1α Differentially in Cancer and Ischemia. Mol. Cell. Biol. 28 (16), 5106–5119.
Rapisarda, A., Shoemaker, S.H., Melillo, G. (2009). Antiangiogenic agents and HIF-1 inhibitors
meet at the crossroads. Cell Cycle, 8 (24), 4040-4043.
Rosen, L.S. (2002). Clinical experience with angiogenesis signaling inhibitors: focus on
vascular endothelial growth factor (VEGF) blockers. Cancer Control, 9:, 36-44.
Sato, T.N., (2003), Emerging concept in angiogenesis: specification of arterial and venous
endothelial cells, Br. J. Pharmacol., 140, 611-613.
Sihvo, E.I.T., Ruohtula, T., Auvinen, M.I., Koivistoinen, A., Harjula, A.L., Salo, J.A. (2003).
Simultaneous progression of oxidative stress and angiogenesis in malignant transformation
of Barrett esophagus. J Thorac Cardiovasc. Surg., 126 (6), 1952-1957.
Tandon, V.R., Sharma, S., Mahajan, A., Bardi, G.H. (2005). Oxidative Stress: A Novel
Strategy in Cancer Treatment. JK SCIENCE, 7 (1), 1-5.
Ushio-Fukai, M. (2006). Redox signaling in angiogenesis: Role of NADPH oxidase.
Cardiovasc. Res., 71, 226 - 235.
Ushio-Fukai, M. and Nakamura, Y. (2008), Reactive Oxygen Species and Angiogenesis:
NADPH Oxidase as Target for Cancer Therapy. Cancer Lett., 266, 37-52.
van der Bij G.J., Oosterling S.J., Meijer S., Beelen R.H., van Egmond M., (2005) The role of
macrophages in tumor development. Cell Oncol., 27 (4), 203-213.
Wang, J., Yi, J. (2008). Cancer cell killing via ROS. Cancer Biol. Ther., 7 (12), 1875-1884.
Wienberg, F., Hamanak, R., Wheaton, W.W., Weinberg, S., Josep, J., Lopez, L., Kalyanaraman,
B., Mutlu, G.M., Budinger, G.R.S., Chandel, N.S. (2010). Mitochondrial metabolism
and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad.
Sci. USA., 107 (19), 8788-8793.
Xia, C., Meng, Q., Liu, L-Z., Rojanasakul, Y., Wang, X-R., and Jiang, B-H. (2007). Reactive
Oxygen Species Regulate Angiogenesis and Tumor Growth through Vascular
Endothelial Growth Factor. Cancer Res., 67 (22), 10823-10830.
Zou, W. (2005). Immunosuppressive networks in the tumour environment and their therapeutic
relevance. Nature Rev. Cancer, 5, 263–274.
118